Paul F Dellaripa
Overview
Explore the profile of Paul F Dellaripa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Venkat R, Hayashi K, Juge P, McDermott G, Paudel M, Wang X, et al.
Clin Rheumatol
. 2024 Jun;
43(8):2453-2466.
PMID: 38898318
We aimed to determine the prevalence and outcomes for forced vital capacity percent predicted (FVCpp) decline among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). We identified patients with RA-ILD...
13.
Hayashi K, McDermott G, Juge P, Moll M, Cho M, Wang X, et al.
RMD Open
. 2024 Jun;
10(2).
PMID: 38886003
Objective: To compare longitudinal changes in spirometric measures between patients with rheumatoid arthritis (RA) and non-RA comparators. Methods: We analysed longitudinal data from two prospective cohorts: the UK Biobank and...
14.
Dellaripa P, Sung L, Bain P, Lanata C, Blazer A, Miller F, et al.
Arthritis Rheumatol
. 2024 May;
76(10):1459-1466.
PMID: 38751102
Objective: Increases in global temperatures and extreme weather events associated with climate change have complex yet poorly understood detrimental impacts on human health. We reviewed the current published literature on...
15.
Elahee M, Mueller A, Wang R, Marks K, Sasaki T, Cao Y, et al.
ACR Open Rheumatol
. 2024 May;
6(7):429-439.
PMID: 38698736
Objective: T cells contribute to tissue injury in systemic sclerosis (SSc), yet the specific T cell subsets expanded in patients with SSc remain incompletely defined. Here we evaluated specific phenotypes...
16.
Juge P, Dellaripa P, Sparks J
Arthritis Rheumatol
. 2024 Feb;
76(7):999-1001.
PMID: 38360061
No abstract available.
17.
Doyle T, Juge P, Peljto A, Lee S, Walts A, Esposito A, et al.
Thorax
. 2023 Dec;
79(2):182-185.
PMID: 38071573
Shortened telomere lengths (TLs) can be caused by single nucleotide polymorphisms and loss-of-function mutations in telomere-related genes (TRG), as well as ageing and lifestyle factors such as smoking. Our objective...
18.
Juge P, Hayashi K, McDermott G, Vanni K, Kowalski E, Qian G, et al.
Semin Arthritis Rheum
. 2023 Dec;
64:152312.
PMID: 38056314
Objective: Our aim was to investigate the effectiveness and tolerability of antifibrotics in a real-world cohort of patients with rheumatoid arthritis-associated interstitial lung diseases (RA-ILD). Methods: In this retrospective cohort...
19.
McDermott G, Hayashi K, Yoshida K, Juge P, Moll M, Cho M, et al.
Rheumatology (Oxford)
. 2023 Dec;
64(1):133-142.
PMID: 38048611
Objectives: There have been limited investigations of the prevalence and mortality impact of quantitative CT (QCT) parenchymal lung features in RA. We examined the cross-sectional prevalence and mortality associations of...
20.
McDermott G, Hayashi K, Yoshida K, Moll M, Cho M, Doyle T, et al.
Rheumatology (Oxford)
. 2023 Oct;
62(SI3):SI286-SI295.
PMID: 37871923
Objective: To investigate the prevalence and mortality impact of interstitial lung abnormalities (ILAs) in RA and non-RA comparators. Methods: We analysed associations between ILAs, RA, and mortality in COPDGene, a...